249 related articles for article (PubMed ID: 17548187)
21. A multiplex PCR-based reverse line blot hybridization (mPCR/RLB) assay for detection of bacterial respiratory pathogens in children with pneumonia.
Wang Y; Kong F; Yang Y; Gilbert GL
Pediatr Pulmonol; 2008 Feb; 43(2):150-9. PubMed ID: 18085683
[TBL] [Abstract][Full Text] [Related]
22. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.
Moran GJ; Rothman RE; Volturo GA
Am J Emerg Med; 2013 Mar; 31(3):602-12. PubMed ID: 23380120
[TBL] [Abstract][Full Text] [Related]
23. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.
Micek ST; Kollef KE; Reichley RM; Roubinian N; Kollef MH
Antimicrob Agents Chemother; 2007 Oct; 51(10):3568-73. PubMed ID: 17682100
[TBL] [Abstract][Full Text] [Related]
24. Clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh.
Bansal S; Kashyap S; Pal LS; Goel A
Indian J Chest Dis Allied Sci; 2004; 46(1):17-22. PubMed ID: 14870864
[TBL] [Abstract][Full Text] [Related]
25. Role of gemifloxacin in community-acquired pneumonia.
Tillotson GS
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
[TBL] [Abstract][Full Text] [Related]
26. Microbiological profile of community-acquired pneumonia in adults over the last 20 years.
Howard LS; Sillis M; Pasteur MC; Kamath AV; Harrison BD
J Infect; 2005 Feb; 50(2):107-13. PubMed ID: 15667910
[TBL] [Abstract][Full Text] [Related]
27. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
Morrissey I; Ge Y; Janes R
Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863
[TBL] [Abstract][Full Text] [Related]
28. [Community-acquired pneumonia: considerations on ambulatory management].
Zanetti G
Schweiz Med Wochenschr; 1997 Mar; 127(13):528-34. PubMed ID: 9190664
[TBL] [Abstract][Full Text] [Related]
29. Etiologies and treatment outcomes for out-patients with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Lulitanond V; Sawanyawisuth K; Lulitanond A; Limpawattana P
Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1261-7. PubMed ID: 16438155
[TBL] [Abstract][Full Text] [Related]
30. Microbial etiology and bacterial resistance.
Manresa F; Dorca J
Semin Respir Infect; 1999 Jun; 14(2):115-27. PubMed ID: 10391406
[TBL] [Abstract][Full Text] [Related]
31. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance.
Rapp RP
Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590
[TBL] [Abstract][Full Text] [Related]
32. Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study.
Ramírez JA;
Semin Respir Crit Care Med; 2005 Dec; 26(6):543-52. PubMed ID: 16388426
[TBL] [Abstract][Full Text] [Related]
33. [National consensus for management of community acquired pneumonia in adults].
Saldías P F; Pérez C C
Rev Chilena Infectol; 2005; 22 Suppl 1():s7-s10. PubMed ID: 16163422
[TBL] [Abstract][Full Text] [Related]
34. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
35. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
[TBL] [Abstract][Full Text] [Related]
36. Current perspective of the HCAP problem: is it CAP or is it HAP?
Polverino E; Torres A
Semin Respir Crit Care Med; 2009 Apr; 30(2):239-48. PubMed ID: 19296421
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of community-acquired pneumonia in older adults: a population-based study.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Raga-Luria X; Gomez-Bertomeu F;
Respir Med; 2009 Feb; 103(2):309-16. PubMed ID: 18804355
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology and mechanisms of pneumonia in adults].
Bergot E
Rev Prat; 2011 Oct; 61(8):1064-7, 1069-70. PubMed ID: 22135968
[TBL] [Abstract][Full Text] [Related]
39. [Etiology of community-acquired pneumonia in immunocompetent adults].
Moreno B R; Riquelme O R
Rev Chilena Infectol; 2005; 22 Suppl 1():s18-25. PubMed ID: 16163415
[TBL] [Abstract][Full Text] [Related]
40. Microbiological diagnosis and antibiotic therapy in patients with community-acquired pneumonia and acute COPD exacerbation in daily clinical practice: comparison to current guidelines.
Reissig A; Mempel C; Schumacher U; Copetti R; Gross F; Aliberti S
Lung; 2013 Jun; 191(3):239-46. PubMed ID: 23564195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
